PABLO LUIS
ORTIZ ROMERO
Catedrático de universidad
Hospital Universitario Puerta de Hierro
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Puerta de Hierro (7)
2023
-
Cost of Treating Cutaneous T-Cell Lymphoma in Spain: Analysis of MICADOS Study Data by Disease Stage
Actas Dermo-Sifiliograficas
2022
-
Activity and safety of topical pimecrolimus in patients with early stage mycosis fungoides (PimTo-MF): a single-arm, multicentre, phase 2 trial
The Lancet Haematology, Vol. 9, Núm. 6, pp. e425-e433
-
EORTC-QLQ-C30 and SKINDEX-29 measurement of health-related quality of life in patients with mycosis fungoides and Sézary syndrome: Real-world data in Spanish patients (MICADOS Study)
JEADV Clinical Practice, Vol. 1, Núm. 4, pp. 438-449
2021
-
EORTC-QLQ-C30 and SKINDEX-29 measurement of health-related quality of life in patients with mycosis fungoides and Sézary syndrome: real-world data in Spanish patients (MICADOS study)
European Journal of Cancer, Vol. 156, pp. S29-S30
2015
2014
-
PIM kinases as potential therapeutic targets in a subset of peripheral T cell lymphoma cases
PLoS ONE, Vol. 9, Núm. 11
-
PLCG1 mutations in cutaneous T-cell lymphomas
Blood, Vol. 123, Núm. 13, pp. 2034-2043